Ignite Creation Date:
2025-12-24 @ 9:55 PM
Ignite Modification Date:
2025-12-30 @ 3:42 PM
Study NCT ID:
NCT06814132
Status:
COMPLETED
Last Update Posted:
2025-10-23
First Post:
2025-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-07
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10-14
Completion Date Type:
ACTUAL
First Submit Date:
2025-02-03
First Submit QC Date:
None
Study First Post Date:
2025-02-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-21
Last Update Post Date:
2025-10-23
Last Update Post Date Type:
ESTIMATED